The extracorporeal membrane oxygenation machine (ecmo) machine market has seen considerable growth due to a variety of factors.
• The market size for the extracorporeal membrane oxygenation machine (ECMO) has seen formidable growth over the recent past. The projections indicate that it will expand from $1.07 billion in 2024 to $1.16 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.59%.
Factors contributing to this growth during the historical phase include the aging population laden with chronic diseases, escalated government funding towards healthcare infrastructure, surging demand in emergency and critical care, the increasing occurrence of diseases associated with lifestyle, and the escalating expenditure on healthcare.
The extracorporeal membrane oxygenation machine (ecmo) machine market is expected to maintain its strong growth trajectory in upcoming years.
• The market for extracorporeal membrane oxygenation (ECMO) machines is projected to witness robust growth in the upcoming years, reaching $1.59 billion by 2029 with a compound annual growth rate (CAGR) of 8.22%.
This growth in the market is anticipated because of factors such as the increased occurrence of cardiovascular and respiratory ailments, rising cardiogenic shock instances, heightened demand for state-of-the-art life-support systems, an expanding number of ECMO centers across the globe, and its growing use in lung transplant procedures. Key trends for this period include the incorporation of artificial intelligence for real-time tracking, the use of augmented reality in ECMO training, technological breakthroughs in ECMO devices, the introduction of cordless ECMO systems, and the adoption of digital twin technology.
Anticipated growth in the extracorporeal membrane oxygenation machine (ECMO) market is tied to the increasing number of lung transplant procedures. The surgical replacement of damaged or unwell lungs with healthy ones from donors is steadily becoming more popular. Factors contributing to this increase include advancements in surgical techniques, improved care post-transplant, and a bigger pool of organ donors. These enhancements lead to enhanced success rates and expanded patient eligibility. The ECMO machine plays a pivotal role, providing critical support for patients severely suffering from respiratory failure. Such support sustains the patient till an apt donor's lung is found. To underline the point, an article in the American Journal of Transplantation, a reputable peer-reviewed medical journal in the US, shows that the US experienced a surge in the number of lung transplants in 2022 - from 2,569 in 2021 to 2,743. This uptick in lung transplant procedures is in turn powering the growth of the ECMO machine market.
The extracorporeal membrane oxygenation machine (ECMO) machine market covered in this report is segmented –
1) By Component: Pumps, Oxygenator, Controllers, Cannula, Accessories
2) By Modality: Veno-Venous, Veno-Arterials, Arterio-Venous
3) By Patient Type: Neonates, Pediatric, Adult
4) By Application: Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation(ECPR)
5) By End Use: Hospitals, Ambulatory Surgical Centers, Research Institutions
Subsegments:
1) By Pumps: Roller Pumps, Centrifugal Pumps
2) By Oxygenator: Hollow Fiber Oxygenators, Flat Sheet Oxygenators, Pediatric Oxygenators
3) By Controllers: Analog Controllers, Digital Controllers, Mobile ECMO Controllers
4) By Cannula: Venous Cannula, Arterial Cannula, Bi-Caval Dual Lumen Cannula
5) By Accessories: Tubing Sets, Blood Filters, Temperature Probes, Hemoconcentrators
In the extracorporeal membrane oxygenation machine (ECMO) market, prominent businesses are concentrating on creating cutting-edge products like configurable one-system ECMO solutions. This is aimed at enhancing patient results, simplifying clinical workflows and increasing usability in critical healthcare settings. Configurable one-system ECMO solutions are adaptable ECMO machines that can be customized to suit the unique needs of individual patients. They provide adjustable settings and elements for the best possible respiratory and cardiac support in a range of clinical situations. For example, Medtronic plc, a US-based medical device firm, unveiled VitalFlow, a configurable ECMO solution in September 2024. This ECMO solution is characterized by its simplicity, making it easy to set up and alter as per the intensive care requirements. It delivers high performance along with advanced monitoring features, guaranteeing the best management of oxygenation and blood circulation. The system is designed to be flexible, supporting both venovenous (VV) and venoarterial (VA) configurations, hence making it highly adaptable for patient needs.
Major companies operating in the extracorporeal membrane oxygenation machine (ECMO) machine market are include:
• Abiomed Inc.
• Abbott Laboratories
• Medtronic plc
• Fresenius Medical Care AG & Co. KGaA
• Terumo Cardiovascular Systems Corporation
• Shenzhen Mindray Biomedical Electronics Co. Ltd.
• Nipro Corporation
• Getinge Group
• LivaNova plc
• MicroPort Scientific Corporation
• Hamilton Medical AG
• Braile Biomédica
• Xenios AG
• Cytosorbents Corporation
• Eurosets S.R.L.
• MC3 Cardiopulmonary
• OriGen Biomedical Inc.
• Inspira Technologies OXY B.H.N. Ltd.
• Technimount System
• Sorin Group
North America was the largest region in the extracorporeal membrane oxygenation machine (ECMO) machine market in 2024. The regions covered in the extracorporeal membrane oxygenation machine (ECMO) machine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.